Diagnostics

Journal Browser

► Journal Browser

Gastroenterology and Hepatology: Diagnostics and Management

Share This Special Issue

Special Issue Editor

Dr. Ishaan Vohra

E-Mail Website
Guest Editor

Department of Gastroenterology and Hepatology, University of Illinois College of Medicine, Peoria, IL 61637, USA
Interests: endoscopic retrograde cholangiopancreatography; endoscopic ultrasound; GI pathology national trends; third-space endoscopy; endoscopic suturing

Special Issue Information

Dear Colleagues,

We are excited to announce our upcoming Special Issue that aims to illuminate the ever-evolving landscape of interventional and general gastroenterology. This Issue will focus on key techniques, including Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasound (EUS), Endoscopic Vacuum Therapy, Third-Space Endoscopy, and Endobariatric procedures, while also addressing nationwide trends in gastroenterology pathologies.

Our primary objective is to elevate patient care through pioneering research, innovative methodologies, and clinical insights that are reshaping the future of gastroenterological interventions. Contributions to this Special Issue will comprehensively delve into ERCP, spotlighting pioneering approaches for diagnosing and treating biliary and pancreatic disorders. EUS will take center stage, providing a platform to discuss refined techniques, procedural advancements, and emerging applications that directly impact patient outcomes. The exploration of Third-Space Endoscopy will unveil minimally invasive techniques for managing complex gastrointestinal conditions, emphasizing novel advancements and their potential to transform patient care.

Furthermore, the Special Issue will shed light on Endobariatric interventions, addressing the pressing need for effective weight management strategies. Cutting-edge research and clinical experiences will offer insights into the evolving landscape of endoscopic weight loss procedures.

This Special Issue will foster a collaborative environment for esteemed experts and researchers in the field of interventional gastroenterology. It serves as a vital platform for knowledge exchange, encouraging dialogue and collaborations that drive the field toward excellence.

We extend a warm invitation to authors from diverse disciplines within gastroenterology to contribute to this insightful and impactful Special Issue. Your contributions will enrich the discourse, advancing patient care and contributing to a healthier future. Together, let us embark on this journey of discovery and innovation in the realm of gastroenterology.

Dr. Ishaan Vohra
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

endoscopic retrograde cholangiopancreatography
endoscopic ultrasound
endo-bariatrics
national trends
third-space endoscopy

Published Papers (2 papers)

Download All Papers

Research

Jump to: Review

11 pages, 2092 KiB

Open AccessArticle

A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population

by Dai Yoshimura, Mitsuharu Fukasawa, Yoshioki Yoda, Masahiko Ohtaka, Tadao Ooka, Shinichi Takano, Satoshi Kawakami, Yoshimitsu Fukasawa, Natsuhiko Kuratomi, Shota Harai, Naruki Shimamura, Hiroyuki Hasegawa, Naoto Imagawa, Yuichiro Suzuki, Takashi Yoshida, Shoji Kobayashi, Mitsuaki Sato, Tatsuya Yamaguchi, Shinya Maekawa and Nobuyuki Enomoto

Diagnostics 2024, 14(6), 651; https://doi.org/10.3390/diagnostics14060651 - 20 Mar 2024

Viewed by 591

Abstract

This study aimed to develop and validate a simple scoring system to determine the high-risk group for pancreatic cancer (PC) in the asymptomatic general population. The scoring system was developed using data from PC cases and randomly selected non-PC cases undergoing annual medical checkups between 2008 and 2013. The performance of this score was validated for participants with medical checkups between 2014 and 2016. In the development set, 45 PC cases were diagnosed and 450 non-PC cases were identified. Multivariate analysis showed three changes in clinical data from 1 year before diagnosis as independent risk factors: ΔHbA1c ≥ 0.3%, ΔBMI ≤ −0.5, and ΔLDL ≤ −20 mg/dL. A simple scoring system, incorporating variables and abdominal ultrasound findings, was developed. In the validation set, 36 PC cases were diagnosed over a 3-year period from 32,877 participants. The AUROC curve of the scoring system was 0.925 (95%CI 0.877–0.973). The positive score of early-stage PC cases, including Stage 0 and I cases, was significantly higher than that of non-PC cases (80% vs. 6%, p = 0.001). The simple scoring system effectively narrows down high-risk PC cases in the general population and provides a reasonable approach for early detection of PC. Full article

(This article belongs to the Special Issue Gastroenterology and Hepatology: Diagnostics and Management)

► Show Figures

Figure 1

Review

Jump to: Research

19 pages, 14763 KiB

Open AccessReview

Imaging of the Liver and Pancreas: The Added Value of MRI

by Giovanni Morana, Alessandro Beleù, Luca Geraci, Luisa Tomaiuolo and Silvia Venturini

Diagnostics 2024, 14(7), 693; https://doi.org/10.3390/diagnostics14070693 - 26 Mar 2024

Viewed by 1285

Abstract

MR is a powerful diagnostic tool in the diagnosis and management of most hepatic and pancreatic diseases. Thanks to its multiple sequences, the use of dedicated contrast media and special techniques, it allows a multiparametric approach able to provide both morphological and functional information for many pathological conditions. The knowledge of correct technique is fundamental in order to obtain a correct diagnosis. In this paper, different MR sequences will be illustrated in the evaluation of liver and pancreatic diseases, especially those sequences which provide information not otherwise obtainable with other imaging techniques. Practical MR protocols with the most common indications of MR in the study of the liver and pancreas are provided. Full article

(This article belongs to the Special Issue Gastroenterology and Hepatology: Diagnostics and Management)

► Show Figures